A Role for SGLT2 Inhibition in Gout? | RheumNow – Rheumatology News & Information

The antidiabetic medication canagliflozin (Invokana) lowered serum urate and reduced the risk of gout flare in a post-hoc analysis of data from two large clinical trials.In the CANVAS clinical trial program, which was funded by Janssen Research & Development and included more than 10,000 patients, the percentage difference in serum urate reduction with canagliflozin versus placebo was 6.7% (95%…

Read the full article here

Related Articles